Shivananda Kandagalla

Molecular docking analysis of curcumin analogues against kinase domain of ALK5

Shivananda Kandagalla, B. S. Sharath, Basavapattana Rudresh Bharath et al. · In Silico Pharmacology · 2017 · 39 citations · Full text

Molecular Docking, Kinase Domain, Medicinal Chemistry +6

Proposition of a new allosteric binding site for potential SARS-CoV-2 3CL protease inhibitors by utilizing molecular dynamics simulations and ensemble docking

Jurica Novak, Hrvoje Rimac, Shivananda Kandagalla et al. · Journal of Biomolecular Structure and Dynamics · 2021 · 28 citations · Full text

Complementarity Principle in Terms of Electron Density for the Study of EGFR Complexes

Shivananda Kandagalla, Hrvoje Rimac, Vladimir Potemkin et al. · Future Medicinal Chemistry · 2021 · 22 citations

Can Natural Products Stop the SARS-CoV-2 virus? a Docking and Molecular Dynamics Study of a Natural Product Database

Jurica Novak, Hrvoje Rimac, Shivananda Kandagalla et al. · Future Medicinal Chemistry · 2021 · 19 citations · Full text

Synthesis, characterization and tumor inhibitory activity of a novel Pd(<scp>ii</scp>) complex derived from methanethiol-bridged (2-((1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)methylthio)-1<i>H</i>-benzo[<i>d</i>]imidazol-6-yl)(phenyl)methanone

Sunil Kumar N., G. Krishnamurthy, Yadav D. Bodke et al. · New Journal of Chemistry · 2018 · 17 citations

Molecular Pharmacology, Medicinal Chemistry, Inhibitory Activity +13